Lavaca Capital LLC lifted its position in shares of The Clorox Company (NYSE:CLX) by 12.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,838 shares of the company’s stock after purchasing an additional 200 shares during the quarter. Lavaca Capital LLC’s holdings in The Clorox were worth $371,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Hall Laurie J Trustee purchased a new stake in shares of The Clorox in the third quarter worth $28,000. Newfound Research LLC bought a new stake in The Clorox in the 3rd quarter worth about $29,000. Rockbridge Investment Management LCC purchased a new position in The Clorox in the 2nd quarter worth about $33,000. Atticus Wealth Management LLC bought a new position in The Clorox during the 3rd quarter valued at about $33,000. Finally, Massmutual Trust Co. FSB ADV boosted its holdings in shares of The Clorox by 57.6% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 208 shares of the company’s stock valued at $44,000 after acquiring an additional 76 shares during the last quarter. 81.73% of the stock is currently owned by institutional investors.

A number of research analysts recently weighed in on CLX shares. JPMorgan Chase & Co. downgraded shares of The Clorox from an “overweight” rating to a “neutral” rating and set a $235.00 price objective on the stock. in a research report on Friday, October 16th. They noted that the move was a valuation call. Wells Fargo & Company assumed coverage on The Clorox in a report on Monday, December 7th. They set an “overweight” rating and a $250.00 price target on the stock. Deutsche Bank Aktiengesellschaft raised their price target on The Clorox from $223.00 to $227.00 and gave the stock a “hold” rating in a research note on Tuesday, November 3rd. DA Davidson upped their price objective on The Clorox from $263.00 to $268.00 and gave the company a “buy” rating in a research report on Tuesday, November 3rd. Finally, BidaskClub cut The Clorox from a “hold” rating to a “sell” rating in a research report on Saturday. Five equities research analysts have rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $220.53.

In other The Clorox news, insider Benno O. Dorer sold 417,022 shares of the company’s stock in a transaction that occurred on Monday, November 30th. The stock was sold at an average price of $200.92, for a total value of $83,788,060.24. Following the completion of the transaction, the insider now directly owns 293,341 shares in the company, valued at approximately $58,938,073.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Diego J. Barral sold 9,916 shares of the company’s stock in a transaction that occurred on Wednesday, December 9th. The stock was sold at an average price of $200.19, for a total value of $1,985,084.04. Following the completion of the transaction, the senior vice president now owns 9,651 shares of the company’s stock, valued at $1,932,033.69. The disclosure for this sale can be found here. Insiders sold a total of 473,319 shares of company stock valued at $95,666,491 in the last quarter. 1.09% of the stock is currently owned by company insiders.

NYSE CLX traded down $0.50 on Wednesday, reaching $193.74. 990,805 shares of the stock were exchanged, compared to its average volume of 1,425,486. The Clorox Company has a one year low of $154.87 and a one year high of $239.87. The firm has a market capitalization of $24.42 billion, a PE ratio of 21.57, a PEG ratio of 4.19 and a beta of 0.21. The company’s 50-day simple moving average is $201.08 and its two-hundred day simple moving average is $213.72. The company has a current ratio of 1.41, a quick ratio of 1.06 and a debt-to-equity ratio of 2.12.

The Clorox (NYSE:CLX) last announced its quarterly earnings data on Saturday, November 7th. The company reported $3.22 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.32 by $0.90. The firm had revenue of $1.92 billion during the quarter, compared to analysts’ expectations of $1.74 billion. The Clorox had a net margin of 16.14% and a return on equity of 132.72%. The company’s revenue for the quarter was up 27.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.59 earnings per share. Sell-side analysts forecast that The Clorox Company will post 8.02 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Shareholders of record on Wednesday, January 27th will be paid a $1.11 dividend. The ex-dividend date is Tuesday, January 26th. This represents a $4.44 dividend on an annualized basis and a yield of 2.29%. The Clorox’s payout ratio is presently 60.33%.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Recommended Story: What is a support level?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.